Skip to content

The difference in colonization capacity between Staphylococcus aureus isolates from human and animal origin

The difference in colonization capacity between Staphylococcus aureus isolates from human and animal origin - The difference between human and animal Staphylococcus aureus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35733
Enrollment
20
Registered
2011-05-10
Start date
2011-06-20
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hospital acquired infection MRSA

Interventions

inoculation in the nose with a mixture of an animal and human S. aureus strain

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy individuals

Exclusion criteria

Exclusion criteria: Diabetes mellitus, renal insufficiency, COPD, heart diseases, immunocompromised status (HIV, AIDS) or use of immunosuppressants, use of antibiotics, allergy for mupirocin of penicillin, skin diseases such as eczema.

Design outcomes

Primary

MeasureTime frame
The survival rate of the animal S. aureus strain in the human nose after the follow-up period of 14 weeks.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)